Yale spinout Halda founded by Craig Crews raises $126M to advance 'hold and kill' solid tumor drugs into the clinic
Halda Therapeutics Secures $126 Million Financing to Advance RIPTAC™ Cancer Therapies into the Clinic for Major Solid Tumors
Avangrid Partners with Yale Startup WindLoop to Test Innovative Process for Wind Turbine Blade Recycling
Nature: BioHaven / Yale Extracellular Targeted Protein Degrader Removes Antibodies in First Test in Humans
